CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation...
Phase 2
Orlando, Florida, United States and 58 other locations
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...
Phase 3
Orlando, Florida, United States and 13 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Orlando, Florida, United States and 335 other locations
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...
Phase 2
DeLand, Florida, United States of America and 70 other locations
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...
Phase 2
Winter Park, Florida, United States and 101 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
Leesburg, Florida, United States and 133 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Orlando, Florida, United States and 83 other locations
This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...
Phase 3
Orlando, Florida, United States and 166 other locations
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...
Phase 4
Winter Park, Florida, United States and 77 other locations
This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.
Phase 1
Orlando, Florida, United States and 13 other locations
Clinical trials
Research sites
Resources
Legal